Jason Haddock Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jason Haddock.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jason Haddock. Jason Haddock is CFO in ARRAY BIOPHARMA INC ($ARRY) and Director in Codiak BioSciences, Inc. ($CDAK).
Latest Insider Trading Transactions of Jason Haddock
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | CDAK | Codiak BioSciences ... | Haddock Jason | Director | Option Exercise | A | 24.13 | 10,000 | 241,300 | 10,000 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 15.97 | 157,500 | 2,515,275 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 10.92 | 168,000 | 1,834,560 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 8.79 | 105,302 | 925,605 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | D | 3.77 | 404,450 | 1,524,777 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | D | 0.00 | 56,026 | 0 | 0 | 56 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | D | 48.00 | 30,059 | 1,442,832 | 56,026 | 86.1 K to 56 K (-34.92 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 3.77 | 85,000 | 320,450 | 404,450 | |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | S | 22.05 | 85,000 | 1,874,301 | 30,059 | 115.1 K to 30.1 K (-73.88 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Buy | M | 3.77 | 85,000 | 320,450 | 115,059 | 30.1 K to 115.1 K (+282.78 %) |
| Feb 08 2019 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | S | 20.00 | 11,712 | 234,240 | 30,059 | 41.8 K to 30.1 K (-28.04 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 0.00 | 7,000 | 0 | 21,000 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 0.00 | 4,387 | 0 | 8,766 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | A | 15.97 | 157,500 | 2,515,275 | 157,500 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | A | 0.00 | 26,250 | 0 | 26,250 | |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Payment of Exercise | F | 15.97 | 5,009 | 79,994 | 41,771 | 46.8 K to 41.8 K (-10.71 %) |
| Dec 18 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Buy | M | 0.00 | 11,387 | 0 | 46,780 | 35.4 K to 46.8 K (+32.17 %) |
| Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | S | 13.92 | 20,000 | 278,400 | 35,393 | 55.4 K to 35.4 K (-36.11 %) |
| Aug 17 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | S | 13.92 | 20,000 | 278,400 | 35,393 | 55.4 K to 35.4 K (-36.11 %) |
| Jul 31 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 3.77 | 51,525 | 194,249 | 489,450 | |
| Jul 31 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | S | 14.87 | 25,000 | 371,750 | 55,393 | 80.4 K to 55.4 K (-31.10 %) |
| Jul 31 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Buy | M | 3.77 | 51,525 | 194,249 | 80,393 | 28.9 K to 80.4 K (+178.48 %) |
| Jan 16 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 3.77 | 14,025 | 52,874 | 540,975 | |
| Jan 16 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Sell | S | 13.73 | 7,500 | 102,975 | 28,868 | 36.4 K to 28.9 K (-20.62 %) |
| Jan 16 2018 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Buy | M | 3.77 | 14,025 | 52,874 | 36,368 | 22.3 K to 36.4 K (+62.77 %) |
| Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | A | 10.92 | 168,000 | 1,834,560 | 168,000 | |
| Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | A | 0.00 | 28,000 | 0 | 28,000 | |
| Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 0.00 | 4,387 | 0 | 13,163 | |
| Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Payment of Exercise | F | 10.92 | 2,044 | 22,320 | 22,343 | 24.4 K to 22.3 K (-8.38 %) |
| Dec 19 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Buy | M | 0.00 | 4,387 | 0 | 24,387 | 20 K to 24.4 K (+21.94 %) |
| Aug 15 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | M | 3.77 | 20,000 | 75,400 | 555,000 | |
| Aug 15 2017 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Buy | M | 3.77 | 20,000 | 75,400 | 20,000 | 0 to 20 K |
| Dec 29 2016 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | A | 8.79 | 105,302 | 925,605 | 105,302 | |
| Dec 29 2016 | ARRY | ARRAY BIOPHARMA IN ... | Haddock Jason | CFO | Option Exercise | A | 0.00 | 17,550 | 0 | 17,550 |
Page: 1